Therefore, the frequency of expression and levels of nucleolin immunoreactivity were further analyzed in stromal tumor endothelial cells (TEC), tumor-infiltrating lymphocytes (TIL), and cancer-associated fusiform cells (including fibroblasts, CAF). This evidence concerns the gene NUCLEOLIN and cancer.